Fertility Treatment News and Research

RSS

New U-M hESC lines now available for federally-funded research

Six new human embryonic stem cell lines derived at the University of Michigan have just been placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research.

15 Jun 2012

Long-lasting weekly fertility injections work as well as daily

New long-lasting weekly injections of fertility hormones are as safe and effective as standard daily injections, according to Cochrane researchers. The researchers compared weekly and daily hormone injections in a Cochrane systematic review and found no difference in pregnancies or serious side effects between the two regimens.

13 Jun 2012

Fertility for older, highly educated women has risen since the 1990s

An increasing number of highly educated women are opting for families, according to a national study co-authored by a University at Buffalo economist.

16 May 2012

Sheffield embryologist given prestigious honour by Health Secretary

Rachel Cutting, Principal Embryologist at the Assisted Conception Unit at Sheffield Teaching Hospitals NHS Foundation Trust, was given the award by Health Secretary Andrew Lansley at the Chief Scientific Officer’s Healthcare Science event last week.

8 May 2012

Eggs developed from stem cells could change reproductive technology

Scientists have developed human egg cells that have been grown entirely in the laboratory from stem cells. These could be fertilized later this year in a development that will revolutionize fertility treatment and might even lead to a reversal of the menopause in older women.

9 Apr 2012

OvaScience completes $37M Series B financing

OvaScience, a fertility company focused on the discovery, development and commercialization of novel treatments for infertility, today announced that it has completed a $37 million Series B financing.

4 Apr 2012

New technique could restore fertility of boys undergoing cancer treatment

Treatments for childhood cancers are increasingly successful with cure rates approaching 80%, but success often comes with a downside for the surviving men: the cancer treatments they received as boys can leave them sterile as adults. Now, a research team led by Ralph Brinster of the University of Pennsylvania School of Veterinary Medicine has completed a 14-year experiment that gives hope for a technique that could restore their fertility.

29 Mar 2012

FMBFarma granted exclusive rights to market Ampio's Zertane for PE in Brazil

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.

22 Mar 2012

New book on reproductive treatments

In Vitro Fertilization [IVF] and the related technologies of assisted reproduction are no longer experimental procedures. In some European countries as many as 4% of all babies born are conceived by IVF, and in every kindergarten classroom there will no doubt be at least one IVF child. Assisted reproduction is the solution to today's epidemic of infertility.

17 Mar 2012

Foreign Policy examines India's growing industry of fertility treatment

Foreign Policy examines "India's flourishing fertility treatment business," a multi-billion dollar industry that "has earned India the dubious reputation of being the world's baby factory."

14 Feb 2012

Older women who become pregnant from egg donation not at greater risk than younger counterparts

Although women over age 50 who become pregnant via egg donation are at an elevated risk for developing obstetrical complications, their complication rates are similar to those of younger recipients, according to a study by Columbia University Medical Center researchers to be published in the February 2012 issue of the American Journal of Perinatology.

1 Feb 2012

Vitrolife, ParentPlus enter collaboration to develop new products for IUI

Vitrolife is entering into a collaboration agreement with ParentPlus LLC, with the aim of developing new products for IUI (Intra-Uterine Insemination, artificial insemination).

11 Nov 2011

Test for ticking biological clock

Researchers from St Andrews University, Scotland have been able to chart the levels of a vital fertility hormone in women of different ages thus essentially detect their biological clocks.

9 Aug 2011

C-sections on the rise: One in three mothers opting for procedure

According to the latest study reports, one in three births in the U.S. are now delivered by Caesarean section, which is an all time high and an increasd of 25 percent over seven years.

24 Jul 2011

Study: 'Vanishing twin' linked to increased risk of congenital malformations

Professor Michael Davies will tell the annual meeting of the European Society of Human Reproduction and Embryology today that the "vanishing twin" phenomenon, in which only one child is born from a pregnancy that originally starts as a multiple pregnancy, is linked to a nearly two-fold increased risk in any congenital malformation and to a nearly three-fold risk of multiple malformations.

6 Jul 2011

Cleavage stage embryo with aneuploidy can undergo genetic normalisation process

Professor William G. Kearns told the annual meeting of the European Society of Human Reproduction and Embryology that a three-day-old embryo with an incorrect number of chromosomes was capable of undergoing "a dynamic process of genetic normalisation" so that by day five, when it had developed to the blastocyst stage, it had become euploid, with the correct number of chromosomes.

5 Jul 2011

ICSI study shows strong increase in first trimester pregnancy loss after the age of 38

The research, presented at the annual conference of the European Society of Human Reproduction and Embryology, also showed that rates of preclinical abortion, miscarriage and overall pregnancy loss during the first trimester remained more or less constant until the age of 34, but increased steadily from the age of 35 onwards.

5 Jul 2011

Study shows effect of maternal height on multiple implantation

The researchers say that this is the first time the effect of maternal height on multiple implantation has been shown.

4 Jul 2011

New model may help reduce multiple pregnancies in women

Dr Jan Holte told the annual meeting of the European Society for Human Reproduction and Embryology, that if this model were to be applied in all fertility clinics, it had the potential to reduce the twin rates to the level of just under two percent seen in the normal population. Already, another four clinics have started to use the model.

4 Jul 2011

New insight into oocyte chromosome abnormalities

Ovarian stimulation undertaken by women of advanced maternal age receiving fertility treatment may be disrupting the normal pattern of meiosis - a critical process of chromosome duplication followed by two specialised cell divisions in the production of oocytes and sperm - and leading to abnormalities of chromosome copy numbers that result in IVF failure, pregnancy loss or, more rarely, the birth of affected children with conditions such as Down's syndrome, which is caused by the inheritance of three copies of chromosome 21.

4 Jul 2011